EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

50 hedge funds and large institutions have $120M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+11
Holders Change %
+28.21%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
13
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
EcoR1 Capital
California
$12.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
$8.32M
3
Jennison Associates
Jennison Associates
New York
$15.3M
4
GC
GMT Capital
Georgia
$3.46M
5
Vanguard Group
Vanguard Group
Pennsylvania
$5.24M

Top Sellers

1
SFM
Sphera Funds Management
Israel
$0
2
PM
Prosight Management
Texas
$5.35M
3
PAWC
P.A.W. Capital
Connecticut
$1.1M
4
HCM
Highbridge Capital Management
New York
$1.72M
5
TCM
Tekla Capital Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TCM
51
Tekla Capital Management
Massachusetts
– -$452K -1,528 Closed
SM
52
Sabby Management
Florida
– -$317K -1,073 Closed
DZ Bank
53
DZ Bank
Germany
– -$227K -769 Closed
WS
54
Wedbush Securities
California
– -$191K -645 Closed
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
– -$621 -2 Closed
1 2
3